With evolving US tariffs, Pakistan’s pharmaceutical industry is well-positioned to capture larger market share, reinforcing its reputation for quality and

𝐏𝐚𝐤𝐢𝐬𝐭𝐚𝐧 𝐚𝐧𝐝 𝐂𝐡𝐢𝐧𝐚 unite to build an advanced antibiotic plant driving innovation, boosting healthcare, and shaping a healthier tomorrow. As

Pakistan’s pharmaceutical industry is making waves internationally, fueled by its high-quality manufacturing and a significant rise in exports. 💊📈 With

Pakistan’s pharmaceutical industry has achieved a historic milestone, with pharmaceutical exports soaring by 34% in the fiscal year 2024-2025 (FY25)

Pakistan Pharma continues to expand its global reach through key strategic partnerships that benefit both local industry and international markets.

PPMA Leadership, led by key executive members, held a productive meeting with DRAP Additional Director Dr. Obaid Ali to discuss

PPMA appreciates the Finance Minister’s recognition and remains committed to strengthening public–private partnerships for a healthier, self-reliant Pakistan.

The Pakistan Pharmaceutical Industry is uniquely positioned to address this national pain point. With promising reforms, digital transformation, and investment

Understanding the Pharmaceutical Industry begins with recognizing a key concern—millions still lack access to essential medicines. Despite global advancements, supply